| US 7,544,786 B2 | ||
| Polynucleotide | ||
| Jan O. Aasly, Trondheim (Norway); Zbigniew K. Wszolek, Jacksonville, Fla. (US); and Matthew J. Farrer, Jacksonville, Fla. (US) | ||
| Assigned to Mayo Foundation for Medical Education and Research, Rochester, Minn. (US) | ||
| Appl. No. 10/568,414 PCT Filed Dec. 19, 2005, PCT No. PCT/NO2005/000465 § 371(c)(1), (2), (4) Date Jul. 12, 2006, PCT Pub. No. WO2006/068492, PCT Pub. Date Jun. 29, 2006. |
||
| Claims priority of application No. 20045612 (NO), filed on Dec. 23, 2004; and application No. 20052535 (NO), filed on May 27, 2005. | ||
| Prior Publication US 2008/0009454 A1, Jan. 10, 2008 | ||
| Int. Cl. C07H 21/02 (2006.01); C07H 21/04 (2006.01) | ||
| U.S. Cl. 536—23.1 [536/24.33] | 5 Claims |
| 1. An isolated polynucleotide consisting of the base sequence of SEQ ID NO:2, or a complementary strand thereto, wherein the nucleotide at position 6055 of SEQ ID NO:2 is A, C or T. |